Is It Time Alpha-1 Antitrypsin Deficiency Had a Specific Patient Reported Outcome Measure? A Review
Joshua De Soyza, Hung-Yeh Chien, Adeola Ayodotun Onasanya, Alice M Turner Institute of Applied Health Sciences, University of Birmingham, Birmingham, UKCorrespondence: Joshua De Soyza, Email j.desoyza@bham.ac.ukAbstract: Alpha-1 antitrypsin deficiency (AATD) is a rare cause of chronic lung and liver...
Saved in:
Main Authors: | De Soyza J, Chien HY, Onasanya AA, Turner AM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-01-01
|
Series: | Patient Related Outcome Measures |
Subjects: | |
Online Access: | https://www.dovepress.com/is-it-time-alpha-1-antitrypsin-deficiency-had-a-specific-patient-repor-peer-reviewed-fulltext-article-PROM |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk of lung disease with the Pi*SS genotype of alpha-1 antitrypsin: the evidence in context
by: Helen O’Brien, et al.
Published: (2025-01-01) -
Alpha-defensins increase NTHi binding but not engulfment by the macrophages enhancing airway inflammation in Alpha-1 antitrypsin deficiency
by: Jungnam Lee, et al.
Published: (2025-02-01) -
Vascular Pathology in Alpha 1 Antitrypsin Deficient Chronic Obstructive Pulmonary Disease and Emphysema Patients: Case Reports
by: Gordon M, et al.
Published: (2025-01-01) -
Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project
by: Teresa Martín, et al.
Published: (2024-06-01) -
Lung transplant outcomes for recipients with alpha-1 antitrypsin deficiency, by use of alpha-1 antitrypsin augmentation therapy
by: Atharv V. Oak, MEng, et al.
Published: (2025-02-01)